Trial intelligence / Profile preview

Dopamine and noradrenaline antagonism in probability and reward value processing

NL-OMON44020Not yet recruiting

Sponsor
Utrecht University
Start
May 2015
Modality
Small Molecules
Countries
1
01

Overview

Trial of clonidine, haloperidol and Placebo-COD Research Private Ltd (3 arms), sponsored by Utrecht University. Primary endpoints: Cue-specific P200 event-related potential relative to no cue and Cue-specific P300 event-related potential relative to no cue. Planned start May 2015; status: not yet recruiting.

02

Drugs

clonidinehaloperidolPlacebo-COD Research Private Ltd

Beyond the preview

Go deeper on NL-OMON44020.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON44020.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call